Status: Recruiting
A Phase 2 Trial Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults With Hypoparathyroidism
The goal of this clinical trial is to investigate the safety, tolerability and efficacy of EXT608 in adults with hypoparathyroidism.
Participants needed: 35
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Extend Biosciences Inc.Updated: May 25, 2025Locations: 1
Eligibility criteria
Ability to personally provide written, signed, and dated informed consent to par... [+8]
Participants with hypoparathyroidism due to an activating mutation of the calciu... [+15]